Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 1
2006 4
2007 2
2011 1
2013 2
2014 1
2015 2
2016 1
2020 2
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Particle-based platforms for malaria vaccines.
Wu Y, Narum DL, Fleury S, Jennings G, Yadava A. Wu Y, et al. Among authors: fleury s. Vaccine. 2015 Dec 22;33(52):7518-24. doi: 10.1016/j.vaccine.2015.09.097. Epub 2015 Oct 11. Vaccine. 2015. PMID: 26458803 Free PMC article. Review.
A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge.
Koopman G, Amacker M, Stegmann T, Verschoor EJ, Verstrepen BE, Bhoelan F, Bemelman D, Böszörményi KP, Fagrouch Z, Kiemenyi-Kayere G, Mortier D, Verel DE, Niphuis H, Acar RF, Kondova I, Kap YS, Bogers WMJM, Mooij P, Fleury S. Koopman G, et al. Among authors: fleury s. Sci Rep. 2023 Mar 28;13(1):5074. doi: 10.1038/s41598-023-31818-y. Sci Rep. 2023. PMID: 36977691 Free PMC article.
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
Lakhashe SK, Amacker M, Hariraju D, Vyas HK, Morrison KS, Weiner JA, Ackerman ME, Roy V, Alter G, Ferrari G, Montefiori DC, Tomaras GD, Sawant S, Yates NL, Gast C, Fleury S, Ruprecht RM. Lakhashe SK, et al. Among authors: fleury s. Front Immunol. 2022 Feb 22;13:788619. doi: 10.3389/fimmu.2022.788619. eCollection 2022. Front Immunol. 2022. PMID: 35273592 Free PMC article.
Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate.
Fernandes B, Sousa M, Castro R, Schäfer A, Hauser J, Schulze K, Amacker M, Tamborrini M, Pluschke G, Alves PM, Fleury S, Roldão A. Fernandes B, et al. Among authors: fleury s. Front Bioeng Biotechnol. 2022 May 20;10:879078. doi: 10.3389/fbioe.2022.879078. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35669054 Free PMC article.
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.
Amacker M, Smardon C, Mason L, Sorrell J, Jeffery K, Adler M, Bhoelan F, Belova O, Spengler M, Punnamoottil B, Schwaller M, Bonduelle O, Combadière B, Stegmann T, Naylor A, Johnson R, Wong D, Fleury S. Amacker M, et al. Among authors: fleury s. NPJ Vaccines. 2020 May 18;5(1):41. doi: 10.1038/s41541-020-0190-9. eCollection 2020. NPJ Vaccines. 2020. PMID: 32435515 Free PMC article.
24 results